Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 9.40
-0.23 (-2.39%)
At close: Mar 17, 2026
Mabion Market Cap
Mabion has a market cap or net worth of 155.64 million as of March 17, 2026. Its market cap has decreased by -8.63% in one year.
Market Cap
155.64M
Enterprise Value
153.95M
Revenue
14.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.40
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 155.64M, an increase of 67.34%. That is a compound annual growth rate of 3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 155.64M | 37.97% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 566.44M |
| Captor Therapeutics Spolka Akcyjna | 444.51M |
| Bioceltix | 391.00M |
| BIOTON | 353.76M |
| Synthaverse | 263.27M |
| Molecure | 127.74M |
| Poltreg | 113.79M |
| NanoGroup | 83.06M |